HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

farletuzumab

a fully humanized MAb that recognizes folate receptor alpha; may be useful in treating ovarian cancer; in phase II clinical trials
Also Known As:
MORAb-003
Networked: 17 relevant articles (2 outcomes, 8 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Coleman, Robert L: 4 articles (03/2015 - 03/2010)
2. Namiki, Masayuki: 2 articles (04/2015 - 11/2012)
3. Sood, Anil K: 2 articles (01/2015 - 03/2010)
4. Grasso, Luigi: 2 articles (11/2013 - 01/2007)
5. Jacob, Sara: 2 articles (11/2013 - 01/2007)
6. Chao, Qimin: 2 articles (11/2013 - 01/2007)
7. Nicolaides, Nicholas C: 2 articles (11/2013 - 01/2007)
8. Kline, J Bradford: 2 articles (11/2013 - 01/2007)
9. Armstrong, Deborah K: 2 articles (06/2013 - 01/2012)
10. Phillips, Martin D: 2 articles (11/2012 - 01/2007)

Related Diseases

1. Ovarian Neoplasms (Ovarian Cancer)
2. Neoplasms (Cancer)
3. Lung Neoplasms (Lung Cancer)
4. Carcinoma (Carcinomatosis)
5. Disease Progression

Related Drugs and Biologics

1. Platinum
2. taxane
3. Carboplatin (JM8)
4. Folic Acid (Vitamin M)
5. Folate Receptor 1
6. farletuzumab
7. MART-1 Antigen
8. Interleukin 1 Receptor Antagonist Protein (Anakinra)
9. Sirolimus (Rapamycin)
10. Simvastatin (Zocor)

Related Therapies and Procedures

1. Therapeutics
2. Intravenous Infusions
3. Heterologous Transplantation (Xenotransplantation)
4. Drug Therapy (Chemotherapy)
5. Radioimmunotherapy